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Abstract: Cyclophosphamide (CPA) is a commonly used chemotherapeutic agent to treat cancer. Among its many side ef-
fects is the well-known consequence on tooth development when administered at early ages. This study elucidated the ef-
fects of CPA on development of the mandibular molar in mice. Mice received a single intraperitoneal injection of CPA at 
different doses and development times. CPA treatment led to weight loss and alopecia but had no effect on disturbances in 
tooth eruption or crown shape. However, at higher doses, there was arrested root development and early apical foramen clo-
sure histologically related to the formation of the cervical loop structure in the apical portion of the root. In cell culture ex-
periments, the Hertwig’s epithelial root sheath cell line (HERS01a) was cultured with or without CPA. At high doses of 
CPA, HERS01a cells showed decreases in E-cadherin expression, while N-cadherin expression was upregulated, indicating 
that this cadherin switch may promote an epithelial-to-mesenchymal transition (EMT)-like phenomenon. These findings 
suggest that administration of high doses of CPA can lead to arrested root development of the molars and an EMT-like phe-
nomenon.
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Introduction
The overall mortality rates of childhood malignant tumors have de-
creased to approximately 20% due to notable improvements in therapies 
and early diagnosis1, 2). Chemotherapy medicines are widely used and 
effective in the treatment of childhood malignant tumors3). Chemothera-
peutic agents are expected to target malignant cells specifically without 
affecting healthy tissue, but there still are many off-target effects of cy-
totoxic treatment. Due to its capacity to interfere with cancer cell divi-
sion, the N-mustard derivative alkylating drug cyclophosphamide (CPA) 
is widely used in the treatment of cancer. 
Despite improving survivorship of children with malignant tumors, 
the long-term effects of chemotherapy also must be considered4, 5). Chil-
dren who receive chemotherapy before the age of five can represent ex-
tensive damage to their dentition, including certain dental anomalies, 
such as hypodontia, microdontia, enamel hypoplasia, dental caries, and 
atypical crown or root formation6, 7). These dental anomalies may lead to 
anatomic, functional, and aesthetic problems, and severe abnormalities 
can cause malocclusion that can affect facial development and impacts 
quality of life6). However, it is difficult to attribute these effects to any 
single or treatment modality, as multimodal therapy is employed in al-
most all childhood malignant tumors8).
Disturbances in tooth eruption can severely impact the oral health 
quality of life for children receiving long-term chemotherapy9). Root 
formation, which causes an overall increase in tooth length, accompa-
nies intraosseous eruption during the emergence process. Therefore, 
atypical root formation induced by antineoplastic therapy may lead to 
disturbances in tooth eruption. Among these problems with root forma-
tion, foreshortening of roots elicited by premature closure of apices re-
sults directly in decreased tooth length and leads to impaired tooth erup-
tion. However, it has been shown that rootless teeth can erupt into the 
mouth10-13). The disruption of root formation and tooth eruption is caused 
by irradiation of the mouth12, 14, 15). This conflicting evidences prompted 
us to investigate possible interactions between root formation and tooth 
eruption. 
Hertwig’s epithelial root sheath (HERS) plays a role in controlling 
root and cementum formation. During the development of the tooth 
root, which starts after crown formation when the enamel tissue has 
reached the future cementoenamel junction, the HERS arises from an 
elongated apical region of the enamel organ and consists of a bilayer ep-
ithelial structure between the dental papilla and dental follicle16). The 
HERS then grows apically and guides root formation, determining the 
size, shape, and number of the tooth’s roots17). During this continuous 
movement of HERS toward the apical portion of the tooth, the HERS 
gives rise to a mesh network via localized apoptosis or epitheli-
al-to-mesenchymal transition (EMT). This network facilitates the inter-
action between epithelial cells from the HERS and cranial neural 
crest-derived mesenchymal cells to develop the formation of cemen-
tum18, 19). Therefore, disturbances in the function of the HERS cells lead 
to impairment in tooth root structure, shape, number, and length as well 
as cementogenesis20). Molecular mechanisms leading to the dysregulated 
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function of HERS cells remain unclear. Thus, this study aims to deter-
mine whether CPA administration influences root development of the 
mandibular molar in the mice. In addition, we investigated the effects of 
CPA on characterization of HERS cells in vitro.
Materials and methods
Experimental design and tissue preparation
The study protocol of all animal experiments was approved by the 
Animal Care and Use Committee of Fukuoka Dental College, Fukuoka, 
Japan (approval no. 17021). Nineteen day-pregnant ICR mice were pur-
chased from KBT Oriental Co., LTD (Tosu, Japan). After birth, the mice 
were housed with their mothers and provided free access to breast milk, 
and they had access to standard solid mouse feed and distilled water ad 
libitum after weaning. 
At 3, 6, and 9 days of age (postnatal (PN) 3, PN 6, and PN 9), mice 
(n = 120)  received a single intraperitoneal injection (100 μl) of CPA 
(Endoxan, Shionogi & Co., Ltd., Tokyo, Japan) at a dose of 50, 100, and 
200 mg/kg body weight. As a control group, additional mice were intra-
peritoneally injected with 100 μl of saline. Body weight and appearance 
were observed daily throughout the experimental period.
At PN14, 21, and 28, mice treated with or without CPA were euthan-
atized by intraperitoneal injection of an overdose of anesthetic agents, 
and their mandibles were removed and dissected. 
Histological analysis
Following autopsy at each time point, unilateral removed mandibles 
were fixed in 4% paraformaldehyde in phosphate buffered saline, decal-
cified in 10% formic acid for 2 weeks at 4°C and were then embedded 
in paraffin. The paraffin-embedded specimens were sagittally cut and se-
rial sections were stained with hematoxylin and eosin (H&E) to visual-
ize any histological changes. 
Micro-computed tomography (micro-CT) analysis
Fixed mandibles were scanned with a micro-CT system (Sky-
scan-1176 micro-CT; Bruker microCT, Kontich, Belgium) operated at 
50 kVp and 500 mA. The scan size of each image was approximately 9 
mm. The anatomical length of the medial root of each molar was meas-
ured along the medial margin of the tooth from the cementoenamel 
junction to the root apex using three-dimensional (3D) analytic software 
(WinROOF, MITANI, Tokyo, Japan). The sizes of the orifice were ob-
served from the apical side and assessed by the inner margin of the apex 
foramina of the medial roots as apex foramen area using ImageJ 1.46r 
software (National Institutes of Health (NIH), Bethesda, MD, USA).
Cell culture and CPA treatment of HERS cells
The HERS cell line, HERS01a, was previously established21). HER-
S01a cells were cultured in Dulbecco’s Modified Eagle Medium: Nutri-
ent Mixture F-12 (Gibco, Grand Island, NY, USA) supplemented with 
B27 (Invitrogen, Carlsbad, CA, USA), fibroblast growth factor-2 (FGF2, 
10 ng/ml, Fiblast Spray, Kaken Pharmaceutical Co., Ltd., Tokyo, Japan), 
epidermal growth factor (EGF, 10 ng/ml, Pepro Tech, Rocky Hill, NJ, 
USA), and penicillin-streptomycin (100 U/ml) in a humidified atmos-
phere of 5% CO2 at 37°C. CPA (0.18, 0.36, and 0.72 μM) was added to 
the culture medium of HERS01a cells in 60-mm dishes or 10-well cul-
ture slides. 
Cell viability assay
To determine CPA sensitivities, cell viability was performed using a 
trypan blue exclusion test. Briefly, HERS01a cells were washed with 
phosphate-buffered saline (PBS), harvested from the dishes via trypsini-
zation, resuspended in PBS, and diluted 1:1 in 0.4% trypan blue solu-
tion. Cell viability was calculated using a Contest Automated Cell 
Counter (Invitrogen) following the manufacturer’s instructions.
Western blot analysis 
The cells were lysed in Cell Lysis Buffer (Cell Signaling Technolo-
gy, Danvers, MA,  USA) containing a 1x Protease/Phosphatase Inhibitor 
Cocktail (Cell Signaling Technology). The protein content was meas-
ured with a protein assay kit (Pierce, Hercules, CA, USA). Protein sam-
ples, together with a protein marker (Precision Plus Protein Western C 
Standards; Bio-Rad, Richmond, CA, USA), were separated on 12% Mi-
ni-Protean TGX gels (Bio-Rad) for 30 min at 200 V. The separated gels 
were transferred to a polyvinylidene fluoride membrane for 3 min using 
the Trans-Blot Turbo Transfer system (Bio-Rad) with Trans-Blot Trans-
fer Packs. Western blots were processed on the iBind Western System 
(Life Technologies, Carlsbad, CA, USA) with anti-β-actin (Bio-Rad) 
,anti-E-cadherin (1:1000; Cell Signaling Technology) and anti-N-cad-
herin (1:1000; Abcam, Cambridge, UK and horseradish peroxidase-con-
jugated anti-rabbit secondary antibodies (Bio-Rad) . The protein bands 
were developed using an enhanced chemiluminescence system (Signal-
Fire Plus ECL Reagent, Cell Signal Technology). Band density was 
quantified using the NIH ImageJ software.
Immunocytochemical analysis 
HERS01a cells treated with or without CPA were cultured on the 10-
well slides and fixed with 4% paraformaldehyde for 10 min and washed 
in 0.3% Triton-X in PBS for 15 min. The cells were incubated with an-
ti-E-cadherin (1:200; Cell Signaling Technology) and anti-N-cadherin 
(1:200; Abcam), at 4°C overnight. After washing with PBS, the cells 
were incubated with anti-rabbit IgG or anti-mouse IgG conjugated with 
Alexa Fluor 488 (1:200; Molecular Probes, Eugene, OR, USA) at room 
temperature for 45 min. To visualize the nuclei, the cells were counter-
stained with 4, 6-diamidino-2-phenylindole (DAPI; Vector Laboratories, 
Inc., Burlingame, CA, USA). 
Statistical analysis 
Statistical analyses were performed with one-way analysis of vari-
ance (ANOVA), and Bonferroni’s multiple comparison test to determine 
the statistical differences among the samples. Data are presented as the 
mean ± standard deviation (SD) and p values < 0.05 were considered to 
be statistically significant. 
Results
Systemic effects of CPA treatment in mice 
We first examined systemic effects of CPA in mice. Body size from 
the experimental groups was smaller than that from the control group at 
each time point (Fig. 1A). Mice treated with 200 mg/kg CPA were 
markedly smaller, compared to the other groups, after PN 21. In the 200 
mg/kg CPA-treated group, there a depression of hair growth that started 
at PN 14, resulting in focal hair loss in the body, compared to the other 
groups (Fig. 1A). After PN 21, rapid alopecia developed in mice treated 
with 200 mg/kg CPA, but mice treated with 50 or 100 mg CPA/kg 
showed no hair loss. Furthermore, the 200 mg/kg group led to gradual 
weight loss at PN 14 and 21 (Fig. 1B). At PN 28, significant weight loss 
was observed in mice treated with 200 mg/kg (53.7 ± 0.14% vs. the con-
trol, p < 0.001), whereas mice treated with doses below 200 mg/kg were 
not effective at countering CPA-induced weight loss. These findings in-
dicate that a dose of 200 mg/kg CPA-induced systemic changes, includ-
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ing alopecia and weight loss in mice, but it was not lethal. 
Effects of CPA treatment on tooth eruption and crown shape 
We examined whether CPA treatment influenced developmental ab-
normalities, including tooth eruption and crown shape. Fig. 2 shows 
macroscopic images of the removed mandibles. At PN 14, a complete 
eruption of the first molar was observed in all groups. There were no 
differences in crown shape morphology of the molar among mice in the 
treated or control groups. These findings indicate that the CPA treatment 
did not effect tooth eruption or lead to abnormal crown shapes. 
CPA treatment induces arrested root development  
To examine the effect of CPA on the root development, we compared 
the length of the medial first molar roots between the control and 
CPA-treated groups (Figs. 3A and B). Root length increased chronologi-
cally in all groups and did not differ significantly among control, 50 mg/
Figure 1. Macroscopic effects of CPA treatment in ICR mice. A: Photographs of mice treated with or without CPA at PN 14, 21, and 28. CPA-re-
lated severity of 200 mg/kg CPA-treated mice can be seen at PN 21 and 28. WT: wild type (control). Arrow, focal hair loss. B: Changes in body 
weight (%) shown as a fraction of body weight in each experimental group and control at PN 14, 21, and 28. The values in the lines are presented 
as mean ± SD. *p < 0.01 vs. the control group.
Figure 2. Effects of CPA on tooth eruption and crown shape. Representative macroscopic images of removed molars at PN 14, 21, and 28. WT: 
wild type (control). Scale bars: 250µm
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kg CPA, and 100 mg/kg CPA groups, whereas there was significantly 
reduced root length in the 200 mg/kg CPA group at all time. Indeed, the 
mean root length in the 200 mg/kg CPA group was approximately 65% 
of that in the control group at PN 21.
We next examined the effect of CPA on apical foramina. Fig. 4 
shows changes in the mean apical foramen area in the medial roots of 
the mandibular first molars from PN 14 to PN 28. The apical foramen 
from all groups decreased in size according to age. In particular, the api-
cal foramen area from mice treated with 200 mg/kg CPA was signifi-
cantly smaller than those from control mice at PN 14 and PN 21 (p < 
0.05). At PN 28, all groups showed almost the same size in the apical 
foramen area. These findings indicate that mice treated with 200 mg/kg 
CPA showed an early completion of root development, compared with 
untreated mice and those treated with low dosages of CPA. 
Histological analysis of root formation in the mandibular molars 
treated with or without CPA 
To elucidate the effects of CPA on the stage of root formation, we 
examined H&E-stained sections of the developing root in the first mo-
lars of the mandible at PN 14, 21, and 28. Fig. 5 shows the histological 
changes in the periapical region of the medial root at each time point. In 
all groups, the medial roots showed a broad root canal and wide opening 
of the root apices at PN 14. At PN 21, epithelial diaphragm appeared in 
the root apex of the 200 mg/kg group, whereas the other groups became 
open. The root canals near the apex became narrow in all groups at PN 
28. Particularly, the root canals in the CPA groups were markedly nar-
rower than those in the control group. A closed apex was observed his-
tologically in the 200 mg/kg group. The histological findings, combined 
with the micro-CT results, suggest that the 200 mg/kg CPA group shows 
an early apical closure in the root of the molars.  
Figure 3. Chronological changes in the length of the medial roots of the mandibular first molars from mice treated with or without CPA at PN 14, 
21, and 28. A: Three-dimensional (3D) structure of the unilateral mandibles. Root length was obtained from micro-CT images of the medial roots 
(arrow) of mandibular first molars through computed 3D reconstruction measured from the cementoenamel junction to the root apex. B: Changes 
in the medial root length at PN 14, 21, and 28. The results are expressed as the mean ± SD. *Statistically significant difference compared with the 
control (p < 0.05). WT: wild type (control). Scale bars: 250µm
Figure 4. Chronological changes of the apical foramina in the medial roots of the mandibular first molars from mice treated with or without CPA. 
A: Micro-CT images of apical foramen areas of the extracted mandibular first molars through computed 3D reconstruction. B: Changes in the 
sizes of the apical foramina in the medial roots at PN14, 21, and 28. The results are expressed as the mean ± SD. *Statistically significant differ-
ence compared with the control (p < 0.05). WT: wild type (control), Scale bars: 250µm
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Effects of CPA on HERS01a cells
To elucidate in vitro effects of CPA on HERS cells, we cultured the 
HERS cell line (HERS01a cells). In the phase contrast images of HER-
S01a cells, cell damage was observed in the HERS01a cells treated with 
CPA, irrespective of CPA concentration (Fig. 6A). Furthermore, we ex-
amined the effects of CPA on cell viability of HERS01a cells using a 
trypan blue dye exclusion assay. The assay showed a significant de-
crease in the viability of HERS01a cells treated with 0.36 μM (82.0 ± 
3.00) and 0.72 μM (68.3 ± 3.51) of CPA, compared with the control (P 
= 0.045 vs. 0.36 μM; P = 0.0003 vs. 0.72 μM) and 0.18 μM CPA groups 
(Fig. 6B). These findings indicate that CPA treatment can affect cell via-
bility of HERS01a cells in a dose-dependent manner. 
Changes in epithelial and mesenchymal characteristics of HERS01a 
cells treated with CPA 
We examined whether characteristics of HERS cells changed due to 
CPA treatment. Expression of E-cadherin, which is known as an epithe-
lial marker in HERS cells, gradually decreased with increased CPA con-
centration. A marked decrease in E-cadherin expression was observed in 
the 0.72 μM CPA group (Fig. 7A), compared with the other groups, in-
dicating that the CPA treatment can induce a loss of cell–cell adhesion 
in the HERS cells. In contrast, N-cadherin expression, which is a relia-
ble marker for mesenchymal components, was expressed in HERS cells 
treated with a high concentration of CPA (Fig. 7A), suggesting that cells 
showing impaired cell–cell contact due to downregulated expression of 
E-cadherin may be susceptible to increased N-cadherin expression. 
We next evaluated immunocytochemical expression of both E-cad-
herin and N-cadherin in HERS cells treated with or without CPA, to elu-
cidate the effect of CPA on their cellular behavior (Fig. 7B). In the con-
trol group, HERS cells that showed a cobblestone-like arrangement, 
revealed membrane-bound expression of E-cadherin, whereas no N-cad-
herin expression was observed. Membrane-bound expression of E-cad-
herin was gradually decreased in HERS cells with increases in CPA 
concentration. In particular, E-cadherin expression nearly disappeared in 
most HERS cells treated with 0.72 μM CPA. Conversely, significant ex-
pression of N-cadherin was observed in cells of the 0.36 and 0.72 μM 
CPA groups. These findings suggest that CPA treatment, particularly at 
higher concentrations, can initiate an EMT-like phenomenon in the 
Figure 5. Histological changes in the root apices of the mandibular first molars. H&E staining shows the medial root of the molars in the control 
and CPA groups at PN 14, 21, and 28. WT: wild type (control), DP: dental pulp, OD: odontoblasts, Black arrow: HERS (Hertwig’s epithelial root 
sheath), Yellow arrows: epithelial diaphragm, Scale bars: 100µm
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Figure 6. In vitro effects of CPA treatment on HERS01a cells. A: Phase contrast images of HERS01a cells. B: Cell viability was determined using 
trypan blue exclusion. Viability of HERS01a cells exposed to different concentrations (0.18, 0.36, and 0.72 μM) of CPA for 48 h. Results are pre-
sented as the percentage of the trypan blue exclusion in untreated cells (control). Data represent mean values ± SD in quadruplicate. * p < 0.05 
vs. the 0.72 μM group. There is no significant difference in groups of columns jointed to horizontal bar. Scale bars: 100µm
Figure 7. Effects of CPA treatment on expression of epithelial and mesenchymal markers in HERS01a cells. A: Protein expression of E-cadherin, 
N-cadherin, and beta-actin in HERS01a cells treated with or without CPA. Quantification of proteins was performed using the NIH ImageJ soft-
ware, and values shown are fold increases normalized to those of b-actin as a control. Similar results were obtained in three independent experi-
ments. Data represent mean values ± SD in quadruplicate. * p < 0.05 vs. the control and 0.18 μM groups. There is no significant difference in 
groups of columns jointed to horizontal bar.
B: Immunofluorescence (green) of E-cadherin and N-cadherin in the cells treated with or without CPA. 4’, 6-Diamidino-2-phenylindole (DPAI) 
was used to label the nuclei (blue). Scale bars: 50µm
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HERS cells.
Discussion
There is strong evidence that supports an association between 
chemotherapy and dental developmental abnormalities, including dental 
genesis, dental hypoplasia, root stunting, and enamel hypoplasia. 
Among those abnormalities, arrested root development, such as short 
V-shaped roots and early apical closure are relatively common findings 
in survivors of childhood cancer22-24). To elucidate the adverse effects of 
CPA on dental root formation, we analyzed morphological changes in 
the molar roots of mice using CT and histological images. Furthermore, 
in vitro cell culture studies investigated the mechanism underlying the 
cellular effects of the CPA treatment on HERS01a cells. Our in vivo and 
in vitro results showed that CPA treatment at the early stages of root for-
mation can induce impaired root development, via a disturbance in epi-
thelial components of HERS cells. 
Treatment with higher dosages of CPA led to the systemic disorders, 
such as weight and hair losses. Both weight loss and alopecia are the 
most common side effects of chemotherapy. In this study mice treated 
with 200 mg/kg CPA revealed remarkable side effects. Although the 200 
mg/kg dose is higher than that used in low- or standard-risk protocols 
postulated by the Tokyo Children’s Cancer Study Groups, high-dosages 
of CPA administration is occasionally used for clinical therapy in certain 
patient groups, such as high-risk or extremely high-risk groups. CPA 
treatment induces these disorders, because its cytotoxic effects rapidly 
attack nonspecifically dividing cells in the body25). Particularly, separa-
tion of hair at the bulb and hair shaft breakage due to impaired prolifera-
tion of the hair follicle matrix keratinocytes can cause chemotherapy-in-
duced alopecia26). Furthermore, mice with these systemic disorders 
showed impairment dental development. 
Our macroscopic and CT images showed no significant changes in 
stages of tooth eruption or crown morphology among all groups. These 
findings were unexpected, because clinical and experimental studies re-
ported that CPA can induce disturbances in tooth development27, 28). As 
the timing of CPA administration did not influence the development 
stages of tooth crown formation, no morphological changes in the crown 
were observed in the molars, irrespective of CPA dosages. These find-
ings are consistent with a recent report that nondividing columnar od-
ontoblasts and ameloblasts in the mice incisor were not affected by CPA 
administration29). Delayed tooth eruption is well-known as a long-term 
side effects of chemotherapy27). Tooth eruption is a complex and tightly 
regulated process that is divided into five stages; preeruptive move-
ments, intraosseous stage, mucosal penetration, preocclusal and post oc-
clusal stages30). Delayed tooth eruption is caused by impairment of the 
pre-eruptive movement in eruptive stages. CPA administration did not 
influence the timing of pre-eruptive movement stage during the process 
of tooth eruption.
High-dosages of CPA administration can induce the arrested root de-
velopment, when compared with the control group and with mice treat-
ed with low dosages of CPA. In this study, the length of the tooth root 
was significantly shorter than that of the other groups. Recent studies re-
ported that CPA administration can result in decreased root length in the 
first molar of rat mandible, indicating that the effects of CPA are corre-
lated with the developmental stage of the tooth27, 28). Consistent with re-
cent report that demonstrated inhibition of root growth in a dose-de-
pendent manner of CPA treatment24, 31), we revealed that the high dosage 
of CPA administration developed decreased root length in the first mo-
lars of the mandibles. Induction of the decreased root length may be ex-
plained by the general effects of CPA administration on arrested mitotic 
activity in the root proliferation zone, consisting of HERS or odonto-
blasts, as it is believed that HERS is important for root formation and 
determines the root shape and size17). Additional abnormality of CPA-in-
duced disturbances in root development induces early closure of the api-
cal foramen. In our histological analysis, the cervical loop structure was 
shown in the apical region of the tooth from mice treated with high dos-
ages of CPA at PN 14. Along with the appearance of the cervical loop 
structure, the direction of HERS cells to the central portion of the apex. 
The change in direction of HERS cells leads to the closure of the apical 
foramen. The apical closure of the tooth implies complete root forma-
tion32). A recent paper speculated that premature closure of apices led to 
decreases in tooth length9). In the high-dosage group, the early closure 
of the apical foramen induced the completion of the root development 
and contributed to the short root length. These findings suggest that the 
inducible change in direction of HERS by CPA administration may lead 
to short root malformation.  
In this study, the results of cell culture experiments, using HERS01a 
cells, revealed that CPA treatment induced dysregulation of HERS cell 
components. Significant changes were observed in HERS cells treated 
with high-dose CPA, and alterations in cellular components were 
dose-dependent. Our western blotting and immunocytochemical analy-
ses confirmed that HERS cells lost E-cadherin expression, while N-cad-
herin expression was upregulated. This phenomenon of cadherin switch 
is known as the EMT33, 34). Recent studies represented that TGF-β stimu-
lation could induce EMT in HERS cells35, 36). Therefore, we postulate 
that CPA treatment can also facilitate EMT-like movement in the HERS 
cells. Downregulated expression of E-cadherin induced by CPA treat-
ment is responsible for the degradation of cell-cell adhesion of HERS. 
From these findings, we speculate that HERS fragmentation induced by 
an EMT-like phenomenon leads to the formation of cervical loop struc-
ture in the apical portion of the root. In contrast to normal root develop-
ment that progressed due to continuous elongation of the cervical loop, 
the CPA-induced cervical loop may prompt an early closure of the api-
cal foramen, resulting in a shorter root. 
Our potential limitation to this study is the lack of direct evidence to 
examine immunohistochemical expression of the EMT-related mole-
cules in the HERS cells of the tooth root in the mandibles of CPA-treat-
ed mice. Further studies are warranted that elucidate the immunohisto-
chemical changes in the EMT-related molecules in HERS cells of 
CPA-treated mice. Moreover, we also must investigate the molecular 
mechanisms for the induction of the EMT in CPA-treated HERS cells. 
In conclusion, the findings of this study shed additional light on the 
effects of CPA on root development abnormalities. Administration of 
high-dose CPA leads to shorter roots that are associated with the early 
closure of the apical foramen. Furthermore, CPA treatment prompts an 
EMT-like phenomenon, suggesting that the EMT-induced formation of 
the cervical loop structure may cause the apical foramen closure and 
lead to shorter roots.
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